Price-to-book below 1 is one of the oldest signals in value investing: you're paying less for the company than the accountants say its net assets are worth. In theory, you could liquidate the business and come out ahead. In practice, it's rarely that simple — but the screen is still one of the most productive starting points for European small cap research.
Here's how to use it correctly, which markets have the highest concentration of sub-book stocks, and how to separate the genuine opportunities from the traps.
What P/B < 1 actually tells you
The price-to-book ratio divides the stock price by book value per share — equity divided by shares outstanding. When P/B falls below 1, the market is valuing the company at less than the accounting value of what it owns minus what it owes.
For banks, this is common and often rational: book value includes loan portfolios where future losses are uncertain, and regulatory capital requirements create constraints on returns that depress valuations. For industrial companies, it's less common and can signal either genuine distress or genuine undervaluation.
Three scenarios produce sub-book valuations:
Structural distress — the business is loss-making or declining. Book value is eroding. The market is discounting future losses into the current price. P/B is below 1 because investors expect book value to shrink. This is a value trap.
Temporary pain — a cyclical business at the bottom of its cycle. Book value is intact, but earnings are compressed. The market prices in pessimism. When the cycle turns, P/B normalises. This is the classic value opportunity.
Structural neglect — a small, illiquid company that generates reasonable returns but has no analyst coverage and few institutional shareholders. Book value is real, profitability is adequate, but the market simply hasn't paid attention. This is the most interesting scenario in European microcaps.
Where European sub-book stocks concentrate
The distribution of P/B < 1 stocks is not uniform across European markets. Based on ScreenerHero data across BME, EPA, XETRA, BIT, STO, OSL, GPW, and other exchanges, the highest concentrations appear in:
Polish GPW small caps — Poland's stock market has a structural valuation discount relative to Western European peers. Many well-run Polish industrials, construction companies, and financial firms trade at P/B between 0.5 and 0.9 with no obvious fundamental reason beyond low international visibility.
Italian Borsa Italiana (BIT) — Italian banks dominate the sub-book list, but there are also legitimate industrial companies — machinery manufacturers, packaging businesses, food distributors — trading at book-value discounts with stable earnings histories.
Austrian VIE — Central European exposure creates a persistent risk discount for Austrian companies. Several Vienna-listed industrials with solid operating histories trade below book.
German XETRA small caps — The DAX is fully valued or expensive. But in the SDAX and entry standard, you find smaller companies in traditional industries trading at 0.7–0.9x book with mid-single-digit ROEs.
Swedish First North — A handful of Swedish small caps in construction and manufacturing trade below book, often because of cyclical headwinds rather than permanent impairment.
The ROE test: separating opportunities from traps
A P/B ratio below 1 with ROE consistently above 8% is a strong combination. It means the company generates acceptable returns on capital but the market values it below what those assets are worth on paper. When that combination persists for 2–3 years, it usually signals structural neglect rather than structural problems.
P/B below 1 with ROE below 5% — and especially below 3% — is usually a warning sign. The company is not covering its cost of capital. Book value is real but the return on it is poor. The stock deserves to trade below book.
The screen that works:
- Exchange: GPW + BIT + VIE + XETRA
- P/B max: 0.9
- ROE min: 6%
- Market cap: €20M–€500M (microcap to small cap range)
- Profit margin min: 2% (filter out persistent loss-makers)
Run this in ScreenerHero and you'll typically see 30–70 companies across European markets. Not all are opportunities — check the debt/equity ratio and the 3–5 year earnings trend before going further.
What to do next with sub-book names
Finding companies that pass the quantitative screen is step one. The qualitative work takes longer:
Check the balance sheet composition. Book value means different things in different industries. A construction company's book value is mostly inventory and receivables — which can be overvalued if projects go wrong. A manufacturing company's book value includes tangible machinery and inventory that is genuinely sellable. Property companies' book value is as reliable as their asset valuations.
Look at the trend in book value. If book value per share has been declining for three consecutive years, the business is destroying value. A P/B of 0.8 on shrinking book value is not cheap.
Understand why it's cheap. Is it illiquid? Is the CEO unknown outside the domestic market? Is the sector out of favour? Is there a governance concern? The reason for the discount matters. Neglect and illiquidity create recoverable discounts. Governance concerns and terminal decline do not.
Look at insider ownership. In European small caps, high insider ownership (30–60%) is often a positive signal for long-term focus. Very low insider ownership in a family-controlled context can signal that management is not aligned with minority shareholders.
Running the screen in ScreenerHero
To find current European microcaps trading below book value, open the ScreenerHero screener and set:
- Exchange: Select the markets you want to cover (GPW, BIT, VIE, XETRA, or all of them)
- P/B max: 1.0 (or 0.8 for a stricter filter)
- ROE min: 6%
- Market cap max: 500M (to focus on smaller companies)
- Sort by: P/B ascending — lowest P/B names appear first
Add a profit margin minimum (2–3%) to remove persistent loss-makers. The results update in real time as you add and remove filters.
The stocks at the top of the list are the ones the market prices most pessimistically relative to book value. Start with the ones that also have positive ROE and stable earnings — those are the candidates worth spending time on.
ScreenerHero covers all active instruments on BME, EPA, XETRA, BIT, STO, OSL, GPW, AMS, and more. Fundamental data is sourced from financial filings and updated daily. Some small and microcap names may have incomplete data.